NRX PHARMACEUTICALS INC (NRXP) Stock Cash Flow
NASDAQ:NRXP - Nasdaq - US6294442099 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -20.38M | -30.15M | -39.75M | -93.06M | -1.09M | |||
| Depreciation Amortization | 5.00K | 5.00K | 4.00K | 2.00K | N/A | |||
| Change In Working Capital | 7.80M | 5.16M | 699.00K | -4.90M | 187.90K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 845.00K | 3.32M | -704.00K | 60.26M | 303.00K | |||
| OPERATING CASH FLOW | -11.73M | -21.66M | -39.76M | -37.70M | -598.60K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 1.00K | -3.00K | -10.00K | -7.00K | N/A | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 26.18M | |||
| INVESTING CASH FLOW | 1.00K | -3.00K | -10.00K | -7.00K | 26.18M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.66M | -3.09M | 9.50M | -1.28M | 720.30K | |||
| Stock Issued/Repurchased | 5.91M | 9.29M | 22.71M | 53.68M | -26.30M | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | 11.05M | N/A | |||
| FINANCING CASH FLOW | 4.47M | 6.20M | 32.21M | 63.46M | -25.58M | |||
| CHANGE IN CASH | -7.26M | -15.46M | -7.55M | 25.75M | 400.00 | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.73M | -21.66M | -39.76M | -37.70M | -598.60K | |||
| Capital Expenditure | 1.00K | -3.00K | -10.00K | -7.00K | N/A | |||
| FREE CASH FLOW | -11.73M | -21.66M | -39.77M | -37.71M | -598.60K | |||
All data in USD